Allergan Wins Patent Suit


Irvine-based Allergan is reporting this morning that it has won a patent infringement case against Exela PharmSci, Inc., Allergan said the court has ruled that all five patents owned by Allergan are valid and enforceable. The win means that those firms will have to wait until 2022 for approval of their generic products. Tags: allergan patent lawsuit ocular drug lifescience